Bio-AMD, Inc. Stock

Bio-AMD, Inc. is engaged in developing its Point Of Care (POC) medical diagnostic device business, and commercializing its WOCU-based currency risk mitigation business. The Company operates through two segments: the development of a technology designed to mitigate currency risk through its subsidiary, WOCU Limited (WL), and the development of hand held, electronic medical diagnostic devices capable of reading third party assays through its other subsidiary, Bio-AMD Holdings Limited. It offers a disposable micro-fluidic test strip, which is used to measure prothrombin time/international normalized ratio (PT/INR) through a POC blood coagulation monitoring device (COAG) enabling patient-based, anticoagulant drug therapy monitoring. It also offers a Digital Strip Reader (DSR), which enables to read a range of lateral flow-based immunoassay diagnostic test strips, including cardiac markers, infectious diseases, drugs of abuse and female wellbeing, to provide semi-quantitative results.